Susceptibility of gram-negative bacteria andStaphylococcus aureus to combinations of ticarcillin and clavulanic acid
- 1 December 1983
- journal article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 2 (6) , 541-547
- https://doi.org/10.1007/bf02016562
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Pharmacokinetics and tissue penetration of ticarcillin combined with clavulanic acidAntimicrobial Agents and Chemotherapy, 1983
- Amoxycillin/Clavulanic AcidDrugs, 1981
- Augmentin (amoxycillin and clavulanic acid) therapy in complicated infections due to β-lactamase producing bacteriaJournal of Antimicrobial Chemotherapy, 1981
- TicarcillinDrugs, 1980
- In vitro synergistic properties of clavulanic acid, with ampicillin, amoxycillin and ticarcillinJournal of Antimicrobial Chemotherapy, 1980
- CLAVULANIC ACID AND AMOXYCILLIN: A CLINICAL, BACTERIOLOGICAL, AND PHARMACOLOGICAL STUDYThe Lancet, 1980
- Effect of clavulanic acid and amoxycillin formulation against β-lactamase producing Gram-negative bacteria in urinary tract infectionsJournal of Antimicrobial Chemotherapy, 1979
- A study of urinary tract infection in general practiceJournal of Infection, 1979
- BRONCHOPULMONARY INFECTION DUE TO β-LACTAMASE-PRODUCING BRANHAMELLA CATARRHALIS TREATED WITH AMOXYCILLIN/CLAVULANIC-ACIDThe Lancet, 1978
- In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillinAntimicrobial Agents and Chemotherapy, 1978